Sales rise 16.82% to Rs 9.17 crore
Net profit of Sandu Pharmaceuticals declined 31.25% to Rs 0.11 crore in the quarter ended December 2013 as against Rs 0.16 crore during the previous quarter ended December 2012. Sales rose 16.82% to Rs 9.17 crore in the quarter ended December 2013 as against Rs 7.85 crore during the previous quarter ended December 2012. ParticularsQuarter EndedDec. 2013Dec. 2012% Var.Sales9.177.85 17 OPM %5.236.37 -PBDT0.270.37 -27 PBT0.140.26 -46 NP0.110.16 -31Powered by Capital Market - Live News